1. Home
  2. SBLK vs SUPN Comparison

SBLK vs SUPN Comparison

Compare SBLK & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Star Bulk Carriers Corp.

SBLK

Star Bulk Carriers Corp.

HOLD

Current Price

$27.33

Market Cap

2.7B

ML Signal

HOLD

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$50.52

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SBLK
SUPN
Founded
2006
2005
Country
Greece
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
3.0B
IPO Year
2007
2010

Fundamental Metrics

Financial Performance
Metric
SBLK
SUPN
Price
$27.33
$50.52
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$25.50
$61.60
AVG Volume (30 Days)
910.6K
632.7K
Earning Date
05-20-2026
05-05-2026
Dividend Yield
2.33%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$392,755,000.00
Revenue This Year
$11.56
$22.70
Revenue Next Year
N/A
$19.14
P/E Ratio
$47.06
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.78
$31.16
52 Week High
$27.25
$59.68

Technical Indicators

Market Signals
Indicator
SBLK
SUPN
Relative Strength Index (RSI) 74.32 50.83
Support Level $18.09 $47.85
Resistance Level N/A $52.26
Average True Range (ATR) 0.66 2.15
MACD 0.20 0.19
Stochastic Oscillator 100.00 56.16

Price Performance

Historical Comparison
SBLK
SUPN

About SBLK Star Bulk Carriers Corp.

Star Bulk Carriers Corp provides seaborne transportation solutions in the dry bulk sector. The company owns and operates dry bulk carrier vessels, which are used to transport bulk, such as iron ore, coal, grains, bauxite, fertilizers, and steel products. It owns a fleet of vessels that consists of Newcastlemax, Capesize, Post Panamax, Kamsarmax, Panamax, Ultramax, and Supramax. The firm generates the majority of its revenue from Time charters and Voyage charters.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

Share on Social Networks: